A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
Description: Narrative: This project will demonstrate the clinical reliability of a new epigenetic test for smoking cessation treatment and advance it to FDA approval.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R44
Start date: 2016-09-15
End date: 2019-08-31
Investigator: ROBERT A PHILIBERT
Institution: BD HOLDING, INC.
Funded outputs count: 14
Funder award ID: R44CA213507
OpenAlex ID: G6423291161
